Swiss Life Asset Management’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $498K | Buy |
7,428
+793
| +12% | +$58K | ﹤0.01% | 959 |
|
|
2026
Q1 | $506K | Buy |
6,635
+1,395
| +27% | +$101K | ﹤0.01% | 861 |
|
|
2025
Q4 | $334K | Hold |
5,240
| – | – | ﹤0.01% | 973 |
|
|
2025
Q3 | $330K | Sell |
5,240
-9,416
| -64% | -$657K | ﹤0.01% | 863 |
|
|
2025
Q2 | $1.09M | Buy |
14,656
+6,858
| +88% | +$539K | 0.01% | 617 |
|
|
2025
Q1 | $687K | Buy |
7,798
+3,239
| +71% | +$306K | 0.01% | 646 |
|
|
2024
Q4 | $416K | Buy |
4,559
+578
| +15% | +$59.3K | ﹤0.01% | 667 |
|
|
2024
Q3 | $445K | Buy |
3,981
+547
| +16% | +$54.7K | 0.01% | 549 |
|
|
2024
Q2 | $336K | Sell |
3,434
-1,146
| -25% | -$114K | ﹤0.01% | 518 |
|
|
2024
Q1 | $459K | Sell |
4,580
-38,123
| -89% | -$3.35M | 0.01% | 447 |
|
|
2023
Q4 | $3.84M | Buy |
42,703
+20,233
| +90% | +$1.61M | 0.05% | 362 |
|
|
2023
Q3 | $1.72M | Hold |
22,470
| – | – | 0.03% | 506 |
|
|
2023
Q2 | $1.88M | Sell |
22,470
-3,894
| -15% | -$317K | 0.03% | 497 |
|
|
2023
Q1 | $2.22M | Sell |
26,364
-2,782
| -10% | -$239K | 0.03% | 478 |
|
|
2022
Q4 | $2.37M | Sell |
29,146
-8,620
| -23% | -$694K | 0.04% | 409 |
|
|
2022
Q3 | $2.68M | Sell |
37,766
-136
| -0.4% | -$12.2K | 0.05% | 395 |
|
|
2022
Q2 | $3.4M | Sell |
37,902
-16,002
| -30% | -$1.66M | 0.06% | 360 |
|
|
2022
Q1 | $6.04M | Sell |
53,904
-622
| -1% | -$72.9K | 0.08% | 251 |
|
|
2021
Q4 | $6.59M | Buy |
54,526
+153
| +0.3% | +$17K | 0.09% | 266 |
|
|
2021
Q3 | $5.48M | Buy |
54,373
+8,273
| +18% | +$913K | 0.08% | 282 |
|
|
2021
Q2 | $5.38M | Sell |
46,100
-32,016
| -41% | -$3.84M | 0.05% | 312 |
|
|
2021
Q1 | $8.6M | Buy |
78,116
+1,042
| +1% | +$113K | 0.12% | 205 |
|
|
2020
Q4 | $7.73M | Buy |
77,074
+74,507
| +2,902% | +$6.91M | 0.11% | 213 |
|
|
2020
Q3 | $200K | Sell |
2,567
-24,052
| -90% | -$1.81M | ﹤0.01% | 469 |
|
|
2020
Q2 | $1.85M | Buy |
26,619
+22,162
| +497% | +$1.4M | 0.03% | 337 |
|
|
2020
Q1 | $208K | Buy |
+4,457
| New | +$286K | ﹤0.01% | 487 |
|
|
2019
Q4 | – | Sell |
-14,546
| Closed | -$1.07M | – | 513 |
|
|
2019
Q3 | $1.07M | Buy |
14,546
+8,849
| +155% | +$635K | 0.01% | 393 |
|
|
2019
Q2 | $443K | Buy |
5,697
+3,058
| +116% | +$232K | 0.01% | 475 |
|
|
2019
Q1 | $200K | Buy |
+2,639
| New | +$210K | ﹤0.01% | 496 |
|
|
2018
Q4 | – | Sell |
-6,213
| Closed | -$595K | – | 278 |
|
|
2018
Q3 | $595K | Sell |
6,213
-12,011
| -66% | -$1.19M | 0.01% | 432 |
|
|
2018
Q2 | $1.82M | Buy |
18,224
+939
| +5% | +$99.1K | 0.03% | 321 |
|
|
2018
Q1 | $1.82M | Buy |
17,285
+1,340
| +8% | +$135K | 0.03% | 316 |
|
|
2017
Q4 | $1.48M | Sell |
15,945
-13,057
| -45% | -$1.19M | 0.03% | 274 |
|
|
2017
Q3 | $2.62M | Buy |
29,002
+14,326
| +98% | +$1.22M | 0.07% | 175 |
|
|
2017
Q2 | $1.23M | Buy |
14,676
+201
| +1% | +$16.2K | 0.03% | 268 |
|
|
2017
Q1 | $1.17M | Buy |
+14,475
| New | +$1.14M | 0.03% | 249 |
|
|
2016
Q3 | – | Sell |
-9,036
| Closed | -$613K | – | 420 |
|
|
2016
Q2 | $613K | Buy |
9,036
+2,078
| +30% | +$153K | 0.03% | 215 |
|
|
2016
Q1 | $503K | Buy |
6,958
+3,018
| +77% | +$198K | 0.02% | 270 |
|
|
2015
Q4 | $266K | Buy |
3,940
+493
| +14% | +$34.5K | 0.01% | 288 |
|
|
2015
Q3 | $223K | Buy |
3,447
+551
| +19% | +$40.7K | 0.01% | 292 |
|
|
2015
Q2 | $237K | Buy |
+2,896
| New | +$223K | 0.01% | 263 |
|
Other funds holding EMN
DC
Swiss Life Asset Management's EMN Position: Q2 2026 in Review
Swiss Life Asset Management increased its Eastman Chemical (EMN) stake by 12% in Q2 2026, buying an estimated $58K and bringing the position to 7,428 shares worth $498K. The position accounts for ﹤0.01% of the portfolio, ranked #959.
Swiss Life Asset Management first reported a position in EMN in Q2 2015 and has held it in 41 quarters since. The position peaked at $8.6M in Q1 2021. 453 funds tracked by Wall St. Rank hold EMN as of Q2 2026.
- Swiss Life Asset Management held 7,428 shares of Eastman Chemical worth $498K as of Q2 2026.
- Swiss Life Asset Management bought 793 Eastman Chemical shares in Q2 2026, an estimated $58K.
- Eastman Chemical made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #959 holding.
- Swiss Life Asset Management first reported a position in Eastman Chemical in Q2 2015 and has held it in 41 quarters since.
- Swiss Life Asset Management's Eastman Chemical position peaked at $8.6M in Q1 2021.
- 453 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.
Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.